APA (7th ed.) Citation

S, Y., C, D., M, O., M, F., C, C., R, P., . . . N, S. (2020). MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma. Nanomedicine : nanotechnology, biology, and medicine, 24, 102127. https://doi.org/10.1016/j.nano.2019.102127

Chicago Style (17th ed.) Citation

S, Yoshida, et al. "MXD3 Antisense Oligonucleotide with Superparamagnetic Iron Oxide Nanoparticles: A New Targeted Approach for Neuroblastoma." Nanomedicine : Nanotechnology, Biology, and Medicine 24 (2020): 102127. https://doi.org/10.1016/j.nano.2019.102127.

MLA (9th ed.) Citation

S, Yoshida, et al. "MXD3 Antisense Oligonucleotide with Superparamagnetic Iron Oxide Nanoparticles: A New Targeted Approach for Neuroblastoma." Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 24, 2020, p. 102127, https://doi.org/10.1016/j.nano.2019.102127.